Clinical Trials Browser

Has announcements × Carcinoma, Squamous Cell × pembrolizumab × Clear all

NCT03284424 2024-08-23

MK-3475-629

Phase 2 Completed

159 enrolled 16 charts 2 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Squamous Cell